LARA: Pembrolizumab plus Lenvatinib in Recurrent Gynaecological Clear Cell Carcinoma Last updated on Jun 8, 2026 Previous GOG 3026: Ribociclib Plus Letrozole in Recurrent Low-Grade Serous Ovarian Carcinoma Next Publications Update # 129
